Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells

被引：0
|
作者：
Johnson, N. [1 ,2 ]
Bentley, J. [1 ]
Wang, L-Z [1 ]
Newell, D. R. [1 ]
Robson, C. N. [1 ]
Shapiro, G. I. [2 ]
Curtin, N. J. [1 ]
机构：
[1] Newcastle Univ, Northern Inst Canc Res, Paul OGorman Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, England
[2] Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA
来源：
BRITISH JOURNAL OF CANCER | 2024年
关键词：
D O I：
10.1038/s41416-024-02813-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：955 / 955
页数：1
相关论文
共 50 条
  • [41] Pre-Clinical Evaluation of Combined Proteasome and Spliceosome Inhibition in Triple Negative Breast Cancer (TNBC)
    Sridhar, Praveen
    Chan, Stefanie
    Petrocca, Fabio
    Lock, Ying-Jie
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : E61 - E61
  • [42] The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
    Stivala, L. A.
    Cazzalini, O.
    Prosperi, E.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (02) : 85 - 96
  • [43] MicroRNA-337-3p impedes breast cancer progression by targeting cyclin-dependent kinase 1
    Kong, Shuxin
    Liu, Jianyang
    Zhang, Bin
    Lv, Feng
    Yu, Yang
    Qin, Tao
    ONCOLOGY LETTERS, 2022, 23 (01)
  • [44] Association of a genetic variant in cyclin-dependent kinase inhibitor 2A gene with the increased risk of breast cancer
    Sales, S. Shahid
    Mehramiz, M.
    Aledavood, S. A.
    Mashhad, M. Joudi
    Simab, S. Ahmadi
    Avan, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [45] Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands
    Luyendijk, Marianne
    Blommestein, Hedwig
    Uyl-de Groot, Carin
    Siesling, Sabine
    Jager, Agnes
    JAMA NETWORK OPEN, 2023, 6 (02) : E2256170
  • [46] Dynein light chain 1 contributes to cell cycle progression by increasing cyclin-dependent kinase 2 activity in estrogen-stimulated cells
    den Hollander, Petra
    Kumar, Rakesh
    CANCER RESEARCH, 2006, 66 (11) : 5941 - 5949
  • [47] AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity
    Yongmin Liu
    Chunhua Lu
    Qiang Shen
    Debbie Munoz-Medellin
    Heetae Kim
    Powel H Brown
    Oncogene, 2004, 23 : 8238 - 8246
  • [48] AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity
    Liu, YM
    Lu, CH
    Shen, Q
    Munoz-Medellin, D
    Kim, H
    Brown, PH
    ONCOGENE, 2004, 23 (50) : 8238 - 8246
  • [49] Interaction of cyclin-dependent kinase 2 and the Lyn tyrosine kinase in cells treated with 1-beta-D-arabinofuranosylctosine
    Yuan, ZM
    Huang, YY
    Kraeft, SK
    Chen, LB
    Kharbanda, S
    Kufe, D
    ONCOGENE, 1996, 13 (05) : 939 - 946
  • [50] Serum thymidine kinase 1 activity as a pharmacodynamics marker of cyclin-dependent kinase 4/6 inhibition in patients with early stage breast cancer receiving neoadjuvant palbociclib
    Liu, N.
    Thomas, S.
    Luo, R.
    Hoog, J.
    Suh, E. M.
    Bergqvist, M.
    Neumueller, M.
    Guo, Z.
    Vij, K.
    Sanati, S.
    Ellis, M.
    Ma, C.
    CANCER RESEARCH, 2017, 77
12345